BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 3030345)

  • 21. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes.
    Klein G
    Bioessays; 2000 May; 22(5):414-22. PubMed ID: 10797481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
    Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
    Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
    Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
    Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myc translocations in B cell and plasma cell neoplasms.
    Janz S
    DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal translocations in leukaemia.
    Gauwerky CE; Croce CM
    Semin Cancer Biol; 1993 Dec; 4(6):333-40. PubMed ID: 8142618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
    Ruzinova MB; Caron T; Rodig SJ
    Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.
    Adams JM; Gerondakis S; Webb E; Corcoran LM; Cory S
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1982-6. PubMed ID: 6572957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription of protooncogenes during stimulation of normal human B lymphocytes.
    Smeland EB; Blomhoff HK; Ohlsson R; De Lange Davies C; Funderud S; Boye E
    Eur J Immunol; 1988 Nov; 18(11):1847-50. PubMed ID: 3060364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
    Bornkamm GW
    Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes.
    Nagy N; Klein G; Klein E
    Semin Cancer Biol; 2009 Dec; 19(6):407-10. PubMed ID: 19874894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines.
    Drexler HG; MacLeod RA; Borkhardt A; Janssen JW
    Leukemia; 1995 Mar; 9(3):480-500. PubMed ID: 7885046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
    IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A murine plasmacytoma with a variant (15;16)(D2/3;B1) translocation that involves the c-myc and lambda light chain gene-carrying chromosomes.
    Sugiyama H; Silva S; Babonits M; Potter M; Klein G; Wiener F
    Cancer Genet Cytogenet; 1990 May; 46(1):93-7. PubMed ID: 2110029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis.
    Dalla-Favera R; Lombardi L; Pelicci PG; Lanfrancone L; Cesarman E; Neri A
    Ann N Y Acad Sci; 1987; 511():207-18. PubMed ID: 2830825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.